Journals / Türk Osteoporoz Dergisi / 2013 / Cilt: 19 - Sayı: 2

Postmenopozal osteoporozda FRAX ile belirlenen kırık riski ve kemik döngüsü belirteçleri arasındaki ilişki

The relationship between the FRAX tool and bone turnover markers in postmenopausal osteoporosis

Pages
38–41
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further studies, in larger groups of patients need to make clear the impact of BTM in this tool.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: In this study, we aimed to show the correlation between the ten-year fracture risk, calculated with FRAX and bone turnover markers (BTM) in a group of postmenopausal women with osteoporosis.
📊
Key Findings & Data:Bone mineral density (BMD) was measured by dual-energy X-ray absorptiometry (DXA), with a Hologic-QDR 4500 plus device.
💡
Conclusion & Impact:Further studies, in larger groups of patients need to make clear the impact of BTM in this tool.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: In this study, we aimed to show the correlation between the ten-year fracture risk, calculated with FRAX and bone turnover markers (BTM) in a group of postmenopausal women with osteoporosis. Meterial and Methods: Twenty-four postmenopausal women diagnosed as osteoporosis were included. Patients were assessed for duration of menopause, secondary diseases, medication, habits of nutrition, previous fracture, and family history of fracture. Weight and height measurements were obtained. Bone mineral density (BMD) was measured by dual-energy X-ray absorptiometry (DXA), with a Hologic-QDR 4500 plus device. The ten-year risk for major as well as hip fractures were calculated with the FRAX tool. Serum calcium, phosphorus, magnesium, 25-OH Vitamin D, parathormone (PTH), alkaline phosphatase (ALP), and biochemical markers of bone formation (Osteocalcin, Bone-ALP) and resorption ( N-terminal collagen type 1 and C terminal collagen type 1) were determined. Results: The mean age of patients was 64.3±8.6 (46-80 years). The mean ten-year major fracture and hip fracture risks were 19.5±6.2% and 16.0±5.1%, respectively. There was a strong correlation between the duration of menopause and hip fracture risk (r: 0.878, p=0.022). There was also a strong relationship between hip fracture risk and NTX (r: 0.759, p=0.042). Conclusion: Resorption markers of bone turnover are relevant components in determining fracture risk. Rate of bone remodeling is a parameter which is not included in the FRAX tool. Since FRAX is an established tool for assessing the ten-year fracture risk, we assessed and found a correlation between hip fracture risk and NTX. Further studies, in larger groups of patients need to make clear the impact of BTM in this tool.

Özet

Amaç: Bu çalışmada postmenopozal osteoporozlu kadınlarda FRAX ile hesaplanan 10 yıllık kırık riski ve kemik döngüsü belirteçleri (KDB) arasındaki ilişkiyi araştırdık. Gereç ve Yöntem: Osteoporoz tanısı konulan 24 postmenopozal kadın çalışmaya dahil edildi. Hastalar menopoz süresi, sekonder hastalıklar, ilaç kullanımı, beslenme durumları, önceki kırık ve ailede geçirilmiş kırık öyküsü yönünden sorgulandı. Boy ve kilo ölçümleri yapıldı. Kemik yoğunluğu ölçümü (KMY) dual enerji X-ray absorbsiyometri yöntemiyle Hologic QDR 4500 cihazı kullanılarak ölçüldü. On yıllık major osteoporotic ve kalça kırık riski FRAX aracıyla hesaplandı. Serum kalsiyum, fosfor, magnezyum, 25-OH vitamin D, parathormon, alkali fosfataz ve kemik yapım (osteokalsin ve kemik-alkali fosfataz) ve yıkım belirteçleri (N-terminal telopeptid kollajen tip 1-NTX ve C-terminal telopeptid kollajen tip 1-CTX) ölçüldü. Bulgular: Hastaların ortalama yaşı 64.3±8.6 (46-80 yaş) idi. Ortalama 10 yıllık major osteoporotik ve kalça kırık riski % 19.5±6.2 ve % 16.0±5.1 olarak hesaplandı. Menopoz süresi ve kalça kırık riski arasında kuvvetli ilişki saptandı (r: 0.878, p=0.022). Kalça kırık riski ve NTX arasında da kuvvetli bir ilişki saptandı (r: 0.759, p=0.042). Sonuç: Kemik döngüsünün yıkım belirteçleri kırık riskini belirlemede kullanılmaktadır. Kemik döngüsünün hızı FRAX aracında bulunmayan bir bileşendir. FRAX 10 yıllık kırık riskini değerlendirmek için kullanılan bir araç olarak kullanıldığından biz de kalça kırık riski ve NTX arasındaki ilişkiyi araştırdık ve kuvvetli ilişki saptadık. FRAX aracında kemik döngüsü belirteçlerinin etkisini araştıran daha fazla sayıda hasta içeren çalışmalara ihtiyaç vardır.

🔖

Cite This Article

BOLAYIRLI, M., TÜZÜN, Ş., AKANIRMAK, Ü., ÖZBAYRAK, S., ULUDAĞ, M. (2022). Postmenopozal osteoporozda FRAX ile belirlenen kırık riski ve kemik döngüsü belirteçleri arasındaki ilişki. Türk Osteoporoz Dergisi, Cilt: 19 - Sayı: 2, 38–41. https://ajindex.com/articles/639864

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Tuzun S, Eskiyurt N, Akarırmak U, Sarıdoğan M, et al. The impact of a FRAX based intervention threshold in Turkey: the FRAX_TURK study. Archives of Osteoporosis. DOI 10.1007/s11657-012-0101-4 2. Tuzun S, Eskiyurt N, Akarırmak U, Sarıdoğan M, et al. Incidence of hip fracture and prevalence of osteoporosis in Turkey: the FRACTURK study. Osteoporos Int 2012
  2. Rebolledo, BJ, Unnanuntana A, Lane JM. A comprehensive approach to fragility fractures. J Orthop Trauma 2011
  3. Villiers TJ. Bone health and osteoporosis in postmenopau- sal women Best Practice & Research Clinical Obstetrics and Gynaecology 2009
  4. Delmas PD, Eastell R, Garnero P, et al. The use of biochemical markers of bone turnover in osteoporosis. Osteoporos Int 2000
  5. 11(Suppl 6):2-17. 6. Patrícia Dreyer P, Vieira JGH. Bone turnover assessment: a good surrogate marker? Arq Bras Endocrinol Metab 2010
  6. Devogelaer JP, Boutsen YB, Gruson D, Manicourt M. Is there a place for bone turnover markers in the assessment of osteopo- rosis and its treatment? Rheum Dis Clin N Am 2011
  7. DOI:10.1016/j.rdc.2011.07.002. 8. Johnell O, Oden A, De Laet C, Garnero P, et al. Biochemical indi- ces of bone turnover and the assessment of fracture probability. Osteoporos Int 2002
  8. Vasikaran S, Eastell R, Bruyere O, et al Markers of bone turnover for the prediction of fracture risk and monitoring of osteopo- rosis treatment: a need for international reference standards. Osteoporos Int 2011
  9. Garnero P, Delmas PD. Biochemical markers of bone turno- ver in osteoporosis. In: Marcus M, Feldman D, Kelsey J (eds). Osteoporosis, vol 2. Academic, San Diego, 2001
  10. Reginster JY, Collette J, Neuprez A, et al. Role of biochemical markers of bone turnover as prognostic indicator of successful osteoporosis therapy. Bone 2008
  11. 36 12. Kanis JA, McCloskey EV, Johansson H, Cooper C, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2013
  12. Rizzoli R, Bruyere O, Cannata-Andiac JB, Devogelaerd JP, et al. Management of osteoporosis in the elderly. Current Medical Research and Opinion 2009
  13. Ivaska KK, Gerdhem P, Väänänen HK, Akesson K, Obrant KJ. Bone turnover markers and prediction of fracture: a prospective follow-up study of 1040 elderly women for a mean of 9 years. J Bone Miner Res 2010
  14. McCloskey EV, Vasikaran S, Cooper C. Official Position